DND PharmaTech Inc (347850)

Currency in KRW
92,400.00
+3,600.00(+4.05%)
Closed·
347850 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
88,900.0094,300.00
52 wk Range
10,125.00200,500.00
Key Statistics
Bid/Ask
92,300.00 / 92,400.00
Prev. Close
88,800
Open
89,200
Day's Range
88,900-94,300
52 wk Range
10,125-200,500
Volume
825.78K
Average Volume (3m)
1.41M
1-Year Change
666.0104%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
347850 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

DND PharmaTech Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

DND PharmaTech Inc Company Profile

D&D Pharmatech Inc. engages in the research and development and manufacturing of pharmaceuticals in South Korea. It develops oral peptides, such as MET-002o, MET-224o, MET-097o, DD03, DD07, and DD14 programs for obesity indications in the development phase; injectable peptides, including DD01 for MASH indications; NLY12 and DD15 for obesity indications; and Pegsebrenatide (NLY01) for Parkinson’s and Alzheimer’s diseases. The company is also involved in the development of TLY012, an injectable protein for systemic sclerosis, liver fibrosis, and chronic pancreatitis indications; NLY02, an oral small molecule for PD and AD indications; and P4M01 for anti-microbial peptide indications. In addition, it develops PMI07, PMI05, and PMI06 for solid tumor imaging biomarker indications; and PMI04 for neuroinflammation indications. The company was founded in 2014 and is based in Seongnam-si, South Korea.

Compare 347850 to Peers and Sector

Metrics to compare
347850
Peers
Sector
Relationship
P/E Ratio
−115.7x−23.9x−0.6x
PEG Ratio
−4.80−0.110.00
Price/Book
53.4x3.5x2.6x
Price / LTM Sales
481.0x22.8x3.3x
Upside (Analyst Target)
-18.3%44.9%
Fair Value Upside
Unlock−2.3%5.6%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-521.00 / --
Revenue / Forecast
969.49M / --
EPS Revisions
Last 90 days

347850 Income Statement

People Also Watch

407,500
196170
+1.12%
501,000
307950
-0.79%
180,000
226950
+12.92%
1,050,000
267260
-5.49%
194,000
298380
+1.52%

FAQ

What Is the DND PharmaTech (347850) Stock Price Today?

The DND PharmaTech stock price today is 92,400.00 KRW.

What Stock Exchange Does DND PharmaTech Trade On?

DND PharmaTech is listed and trades on the KOSDAQ.

What Is the Stock Symbol for DND PharmaTech?

The stock symbol for DND PharmaTech is "347850."

What Is the DND PharmaTech Market Cap?

As of today, DND PharmaTech market cap is 4.02T KRW.

What Is DND PharmaTech's Earnings Per Share (TTM)?

The DND PharmaTech EPS (TTM) is -845.57.

From a Technical Analysis Perspective, Is 347850 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has DND PharmaTech Stock Split?

DND PharmaTech has split 1 times.

What is the current trading status of DND PharmaTech (347850)?

As of Mar 01, 2026, DND PharmaTech (347850) is trading at a price of 92,400.00 KRW, with a previous close of 88,800.00 KRW. The stock has fluctuated within a day range of 88,900.00 KRW to 94,300.00 KRW, while its 52-week range spans from 10,125.00 KRW to 200,500.00 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.